Injection pens for effective clinical trials
Due to the high cost pressure in health services, it is necessary for a drug to be safe, effective and more economical than existing forms of therapy. Haselmeier’s injection pens...
New management organisation of the Haselmeier Group
The Haselmeier Group has restructured its management organisation, introducing a Group Executive Board tasked with coordination and decision-making for all Haselmeier locations. The...
Haselmeier announces the launch of INSUPen® EZ in India by Biocon
Haselmeier announces that Biocon, one of Asia’s premier biotechnology companies, has just launched INSUPen® EZ in India. The INSUPen® EZ is a second generation pen and follows on...
Haselmeier announces the market launch of JuniorSTAR by Sanofi
The new and reusable half-unit insulin pen JuniorSTAR® is now available in Germany.
Haselmeier announces the CE mark for JuniorSTAR half-unit insulin pen
Haselmeier has announced the CE mark of JuniorSTAR® by Sanofi.